Search Results - "Keehlisen, Lynda"
-
1
An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer’s Disease
Published in Dementia and geriatric cognitive disorders extra (16-08-2012)“…Aim: To characterize progression of Alzheimer’s disease (AD) using proton magnetic resonance spectroscopy ( 1 H MRS). Methods: Eleven subjects with mild to…”
Get full text
Journal Article -
2
Performance-Based Measures of Everyday Function in Mild Cognitive Impairment
Published in The American journal of psychiatry (01-07-2010)“…ObjectiveThe view that everyday function is preserved in mild cognitive impairment may be problematic. The objectives of this study were to determine the…”
Get full text
Journal Article -
3
An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer’s Disease
Published in JAD reports (31-07-2024)“…We conducted a small, open-label, pilot study of daratumumab to explore target engagement, safety, and potential efficacy in patients with mild to moderate…”
Get full text
Journal Article -
4
APOE Genotype Modulates Proton Magnetic Resonance Spectroscopy Metabolites in the Aging Brain
Published in Biological psychiatry (1969) (01-05-2014)“…Background Proton magnetic resonance spectroscopy (1 H-MRS) studies on healthy aging have reported inconsistent findings and have not systematically taken into…”
Get full text
Journal Article -
5
The Relational and Item-Specific Encoding Task in Mild Cognitive Impairment and Alzheimer Disease
Published in Dementia and geriatric cognitive disorders (01-12-2016)“…The Relational and Item-Specific Encoding task (RISE) measures episodic memory subcomponents, including item-specific and relational encoding of…”
Get more information
Journal Article -
6
Neurocognitive Profile in Adolescents with Early-Onset Schizophrenia: Clinical Correlates
Published in Biological psychiatry (1969) (01-11-2005)“…Neurocognitive impairments have been documented in adolescents with early-onset schizophrenia (EOS; onset by age 18) and are important treatment targets…”
Get full text
Journal Article